139 related articles for article (PubMed ID: 36345163)
1. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
[TBL] [Abstract][Full Text] [Related]
2. Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.
Hira A; Yabe H; Yoshida K; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Nakamura J; Kojima S; Ogawa S; Matsuo K; Takata M; Yabe M
Blood; 2013 Oct; 122(18):3206-9. PubMed ID: 24037726
[TBL] [Abstract][Full Text] [Related]
3. Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.
Mu A; Hira A; Niwa A; Osawa M; Yoshida K; Mori M; Okamoto Y; Inoue K; Kondo K; Kanemaki MT; Matsuda T; Ito E; Kojima S; Nakahata T; Ogawa S; Tanaka K; Matsuo K; Saito MK; Takata M
Blood; 2021 Apr; 137(15):2021-2032. PubMed ID: 33512438
[TBL] [Abstract][Full Text] [Related]
4. [Genetic analysis of Japanese patients with Fanconi anemia: novel findings].
Mori M; Yabe H; Yabe M; Takata M
Rinsho Ketsueki; 2019; 60(6):691-701. PubMed ID: 31281162
[TBL] [Abstract][Full Text] [Related]
5. The phenotype and clinical course of Japanese Fanconi Anaemia infants is influenced by patient, but not maternal ALDH2 genotype.
Yabe M; Yabe H; Morimoto T; Fukumura A; Ohtsubo K; Koike T; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Hira A; Takata M
Br J Haematol; 2016 Nov; 175(3):457-461. PubMed ID: 27377053
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.
Van Wassenhove LD; Mochly-Rosen D; Weinberg KI
Mol Genet Metab; 2016 Sep; 119(1-2):28-36. PubMed ID: 27650066
[TBL] [Abstract][Full Text] [Related]
7. [A new Fanconi anemia-like disorder, aldehyde degradation deficiency syndrome: two defense mechanisms working together for the genome and hematopoiesis].
Takata M
Rinsho Ketsueki; 2023; 64(7):639-645. PubMed ID: 37544724
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
[TBL] [Abstract][Full Text] [Related]
9. A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
Zamani N; Szymiczek A; Shakeri R; Poustchi H; Pourshams A; Narod S; Malekzadeh R; Akbari MR
PLoS One; 2023; 18(11):e0292611. PubMed ID: 37943872
[TBL] [Abstract][Full Text] [Related]
10. Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2.
Kluźniak W; Szymiczek A; Rodrigue A; Wokołorczyk D; Rusak B; Stempa K; Huzarski T; Gronwald J; Lubiński J; Zamani N; Zhang S; Masson JY; Narod SA; ; Cybulski C; Akbari MR
JCO Precis Oncol; 2022 Apr; 6():e2100450. PubMed ID: 35442721
[TBL] [Abstract][Full Text] [Related]
11. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].
Duan RR; Sun LX; Zhao HW
Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292
[No Abstract] [Full Text] [Related]
14. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F
Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318
[TBL] [Abstract][Full Text] [Related]
15. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
16. The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.
Idogawa M; Mariya T; Tanaka Y; Saito T; Nakase H; Tokino T; Sakurai A
J Hum Genet; 2024 May; 69(5):225-230. PubMed ID: 38409497
[TBL] [Abstract][Full Text] [Related]
17. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
Cheung RS; Taniguchi T
Int J Hematol; 2017 Sep; 106(3):335-344. PubMed ID: 28631178
[TBL] [Abstract][Full Text] [Related]
19. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
[TBL] [Abstract][Full Text] [Related]
20. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
